Misra A - Search Results

1

Inhaled Adjunct Therapy with Second-Line Drug Candidates for Dose Reduction in Chemotherapeutic Regimens for Multi-drug-Resistant Tuberculosis.

Verma S, Dal NK, Srivastava A, Bharti R, Siva Reddy DV, Sofi HS, Roy T, Verma K, Raman SK, Azmi L, Ray L, Mugale MN, Singh AK, Singh J, Griffiths G, Misra A. Verma S, et al. Among authors: misra a. AAPS PharmSciTech. 2023 Jun 8;24(5):130. doi: 10.1208/s12249-023-02585-w. AAPS PharmSciTech. 2023. PMID: 37291443

2

Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.

Yadav AB, Sharma R, Muttil P, Singh AK, Verma RK, Mohan M, Patel SK, Misra A. Yadav AB, et al. Among authors: misra a. Indian J Exp Biol. 2009 Jun;47(6):469-74. Indian J Exp Biol. 2009. PMID: 19634713

3

Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis.

Yadav AB, Muttil P, Singh AK, Verma RK, Mohan M, Agrawal AK, Verma AS, Sinha SK, Misra A. Yadav AB, et al. Among authors: misra a. Tuberculosis (Edinb). 2010 May;90(3):188-96. doi: 10.1016/j.tube.2010.03.001. Epub 2010 Apr 9. Tuberculosis (Edinb). 2010. PMID: 20382085

4

Inhaled drug therapy for treatment of tuberculosis.

Misra A, Hickey AJ, Rossi C, Borchard G, Terada H, Makino K, Fourie PB, Colombo P. Misra A, et al. Tuberculosis (Edinb). 2011 Jan;91(1):71-81. doi: 10.1016/j.tube.2010.08.009. Epub 2010 Sep 27. Tuberculosis (Edinb). 2011. PMID: 20875771 Review.

5

The devil's advocacy: when and why inhaled therapies for tuberculosis may not work.

Yadav AB, Singh AK, Verma RK, Mohan M, Agrawal AK, Misra A. Yadav AB, et al. Among authors: misra a. Tuberculosis (Edinb). 2011 Jan;91(1):65-6. doi: 10.1016/j.tube.2010.10.001. Epub 2010 Nov 23. Tuberculosis (Edinb). 2011. PMID: 21106442

6

Inhaled therapies for tuberculosis and the relevance of activation of lung macrophages by particulate drug-delivery systems.

Verma RK, Singh AK, Mohan M, Agrawal AK, Misra A. Verma RK, et al. Among authors: misra a. Ther Deliv. 2011 Jun;2(6):753-68. doi: 10.4155/tde.11.34. Ther Deliv. 2011. PMID: 22822507 Review.

7

Inhalable microparticles containing nitric oxide donors: saying NO to intracellular Mycobacterium tuberculosis.

Verma RK, Singh AK, Mohan M, Agrawal AK, Verma PR, Gupta A, Misra A. Verma RK, et al. Among authors: misra a. Mol Pharm. 2012 Nov 5;9(11):3183-9. doi: 10.1021/mp300269g. Epub 2012 Sep 27. Mol Pharm. 2012. PMID: 22978290

8

Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice.

Verma RK, Germishuizen WA, Motheo MP, Agrawal AK, Singh AK, Mohan M, Gupta P, Gupta UD, Cholo M, Anderson R, Fourie PB, Misra A. Verma RK, et al. Among authors: misra a. Antimicrob Agents Chemother. 2013 Feb;57(2):1050-2. doi: 10.1128/AAC.01897-12. Epub 2012 Nov 26. Antimicrob Agents Chemother. 2013. PMID: 23183441 Free PMC article.

9

HLA-DRB1*1501 and VDR polymorphisms and survival of Mycobacterium tuberculosis in human macrophages exposed to inhalable microparticles.

Singh AK, Abhimanyu, Yadav AB, Sharma S, Garg R, Bose M, Misra A. Singh AK, et al. Among authors: misra a. Pharmacogenomics. 2013 Apr;14(5):531-40. doi: 10.2217/pgs.13.12. Pharmacogenomics. 2013. PMID: 23556450

10

Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.

Verma RK, Agrawal AK, Singh AK, Mohan M, Gupta A, Gupta P, Gupta UD, Misra A. Verma RK, et al. Among authors: misra a. Tuberculosis (Edinb). 2013 Jul;93(4):412-7. doi: 10.1016/j.tube.2013.02.012. Epub 2013 Apr 3. Tuberculosis (Edinb). 2013. PMID: 23562366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,161 results

Search Page

Filters